Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Classical hematology 1Breast 1

Conditions

Breast Neoplasms 37Neoplasms 2Neoplasm Metastasis 2Venous Thromboembolism 1Recurrent Squamous Cell Lung Carcinoma 1Hormone Receptor Positive Advanced Breast Cancer 1HER2-positive Metastatic Breast Cancer 1DILI 1Cardiovascular Diseases 1Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors 1Breast Neoplasms, Male 1Breast Diseases 1

Interventions

acalabrutinib 2Social Determinants of Health 2Electrocardiography 2Echocardiography 2Blood Specimen Collection 2Aspirin 2zanubrutinib 1ribociclib 1phosphoribosylformylglycinamidine synthetase 1palbociclib 1ibrutinib 1glycidol 1abemaciclib 1Vascular Stiffness 1Testosterone 1Pulse Wave Analysis 1Noninvasive Prenatal Testing 1Magnetic Resonance Spectroscopy 1Health Services Needs and Demand 1Gonadotropin-Releasing Hormone 1Genetic Testing 1Exercise 1Eating 1Diet 1DNA 1Chemoradiotherapy 1Cardiovascular Agents 1Antineoplastic Agents 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Cardiovascular Diseases × palbociclib × Clear all
NCT07008508 2025-06-06

BRAVE-Cyclin

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Active not recruiting
300 enrolled
BreastClassical hematology

Breast Neoplasms, Cardiovascular Diseases, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡